Pembrolizumab induced-C3 glomerulonephritis and RBC cast nephropathy: a case report.

Yang, Zhi; Xu, Huan; Gou, Shenju; Wu, Hongyan; Hu, Zhangxue

Yang, Zhi; Xu, Huan; Gou, Shenju; Wu, Hongyan; Hu, Zhangxue.

Afiliación

Yang Z; Department of Nephrology, West China Hospital, Sichuan University, 37# Guoxue Alley, Wuhou District, Chengdu, 610041, Sichuan Province, China.
Xu H; Department of Pathology, West China Hospital, Sichuan University, 37# Guoxue Alley, Wuhou District, Chengdu, 610041, Sichuan Province, China.
Gou S; Department of Nephrology, West China Hospital, Sichuan University, 37# Guoxue Alley, Wuhou District, Chengdu, 610041, Sichuan Province, China.
Wu H; Department of Nephrology, West China Hospital, Sichuan University, 37# Guoxue Alley, Wuhou District, Chengdu, 610041, Sichuan Province, China.
Hu Z; Department of Nephrology, West China Hospital, Sichuan University, 37# Guoxue Alley, Wuhou District, Chengdu, 610041, Sichuan Province, China. hzxawy@scu.edu.cn.

BMC Nephrol ; 24(1): 145, 2023 05 24.

Article en En | MEDLINE | ID: mdl-37226096

Asunto(s)

Carcinoma de Pulmón de Células no Pequeñas; Glomerulonefritis; Enfermedades Renales; Neoplasias Pulmonares; Masculino; Humanos; Anciano; Creatinina; Diálisis Renal; Glomerulonefritis/inducido químicamente; Glomerulonefritis/diagnóstico

Palabras clave

C3 glomerulonephritis; Immunotherapy; PD-1 inhibitors; Pembrolizumab; RBC cast nephropathy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Glomerulonefritis / Enfermedades Renales / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies Límite: Aged / Humans / Male Idioma: En Revista: BMC Nephrol Asunto de la revista: NEFROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google